Organ-on-a-chip Market Size to Hit New profit-making Growth By 2027Posted by Apeksha on June 30th, 2021 Global Organ-on-a-chip Market Research Report: By Organ Type (Lung-on-Chip, Heart-on-Chip, Liver-on-Chip, Intestine-on-Chip, Kidney-on-Chip, Human-on-Chip), By Application (Drug Discovery, Toxicology Research, Others) and By End-User (Pharmaceutical Companies, Research Organizations, Others) – Forecast to 2027 Market Highlights According to MRFR analysis, Organ-on-a-chip Market Size is expected to register a CAGR of 53% during the forecast period of 2019 to 2025 and was valued at USD 51.3 Million in 2018. Grants by government and non-government entities have been the key drivers for the global OOC industry to date. The ability of OOC models to reduce drug development costs drastically will be a key market driver, which is also expected to fuel market growth. However, stringent drug regulatory processes constitute a significant restraint for the widespread use of OOCs by pharmaceutical companies. Drug regulatory authorities scrutinize the preclinical and clinical investigational data of a drug molecule to validate and approve it. The data generated by testing the drug in animal models and humans are required for the drug approval process. Key Players Some of the key players in the Global Organ-On-a-Chip Market are CN Bio Innovations Limited (UK), Emulate, Inc. (US), TissUse GmbH (Germany), MIMETAS BV (Netherlands), Hµrel Corporation, Nortis, Inc. (US), InSphero (Switzerland), TARA Biosystems, Inc. (US), Axosim (US), Organovo Holdings Inc. (US), BioIVT (US), and HemoShear Therapeutics, LLC (US). Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/organ-on-chip-market-8498 Contact: Akash Anand Market Research Future +1 646 845 9312 Like it? Share it! More by this author |